Bellevue Life Sciences Ac... (BLAC)
undefined
undefined%
At close: undefined
11.32
0.00%
After-hours Dec 12, 2024, 02:38 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income 403.78K -35.39K -3.31K -23.81K
Depreciation & Amortization - - - -
Stock-Based Compensation - - - -
Other Working Capital 517.35K 31.15K 2.85K -
Other Non-Cash Items -2.78M - - -
Deferred Income Tax - - - -
Change in Working Capital 1.55M 31.15K 2.85K -
Operating Cash Flow -818.77K -4.24K -461 -23.81K
Capital Expenditures -4 - - -
Acquisitions - - - -
Purchase of Investments - - - -
Sales Maturities Of Investments - - - -
Other Investing Acitivies -33.83M - - -
Investing Cash Flow -33.83M - - -
Debt Repayment -1.20M 800.00K 100.00K -
Common Stock Repurchased -36.00M - - -
Dividend Paid - - - -
Other Financial Acitivies 7.77M -676.02K 10.00K 86.47K
Financial Cash Flow 34.54M 123.98K -57.44K 86.47K
Net Cash Flow -109.08K 119.74K -57.90K 62.65K
Free Cash Flow -818.77K -4.24K -461 -23.81K